Baha Zengel

Izmir University — Turkey

Biochemistry, Genetics and Molecular Biology · Life Sciences

12h-index684citations71works4.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(28), Breast Lesions and Carcinomas(20), HER2/EGFR in Cancer Research(12), Breast Implant and Reconstruction(11), Cancer Treatment and Pharmacology(6)

Publications70 total

ASO Visual Abstract: Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in the NEOSENTITURK-trials MF18-02/18-03
Annals of Surgical Oncology·2025
A Comprehensive Analysis of Neoadjuvant Chemotherapy in Breast Cancer: Adverse Events, Clinical Response Rates, and Surgical and Pathological Outcomes—Bozyaka Experience
Cancers·2025· 1 citedOpen Access
De-Escalation of Nodal Surgery in Clinically Node-Positive Breast Cancer
JAMA Surgery·2025· 14 citedOpen Access
Is there an MRI characteristic feature that distinguishes a phylloid tumor from a fibroadenoma?
The Annals of Clinical and Analytical Medicine·2025Open Access
Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02/18-03
Annals of Surgical Oncology·2024· 7 cited
Combined analysis of the MF18‐02/MF18‐03 NEOSENTITURK studies: ypN‐positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuvant chemotherapy as long as radiotherapy is provided
Cancer·2024· 6 citedOpen Access
Abstract PS01-01: Feasibility and oncological safety of targeted axillary dissection or sentinel lymph node biopsy in patients with clinically node-positive disease after neoadjuvant chemotherapy in the prospective MF-1803 NEOSENTITURK-study
Cancer Research·2024· 2 cited
Oxidative stress markers in breast cancer
Pamukkale Medical Journal·2024· 1 citedOpen Access
Comprehensive Immunohistochemical Analysis of Epithelial–Mesenchymal Transition Biomarkers in the Invasive Micropapillary Cancer of the Breast
International Journal of Breast Cancer·2024· 2 citedOpen Access
New Lymph Node Parameters and a Comparison with the American Joint Committee on Cancer N-Stages in Breast Cancer
Cyprus Journal of Medical Sciences·2023· 1 citedOpen Access
Abstract PD15-01: PD15-01 AXILLARY NODAL RECURRENCE IS RARE IN PATIENTS WITH NODE-POSITIVE BREAST CANCER UNDERGOING SLNB FOLLOWING NEOADJUVANT CHEMOTHERAPY : EARLY RESULTS OF THE NEOSENTITURK-TRIAL/MF-18-03
Cancer Research·2023
Boards
Turkish Journal of Biochemistry·2023Open Access
The Oncologic Safety of Sentinel Lymph Node Biopsy in Patients with Node-Positive Breast Cancer with Complete Response to Neoadjuvant Chemotherapy: A Single-Center Experience
The Breast Journal·2023· 4 citedOpen Access
Gastrointestinal Tract Metastases of Invasive Lobular Carcinoma of the Breast: An Immunohistochemical Survey Algorithm
European Journal of Breast Health·2022· 9 citedOpen Access
The Importance of the Pathological Perspective in the Management of the Invasive Lobular Carcinoma
The Breast Journal·2022· 3 citedOpen Access
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study
Anti-Cancer Drugs·2022· 3 cited
Prognostic Value of Receptor Change After Neoadjuvant Chemotherapy in Breast Cancer Patients
European Journal of Breast Health·2022· 12 citedOpen Access
Breast cancer patients with isolated bone metastases and oligometastatic bone disease show different survival outcomes
Scientific Reports·2021· 20 citedOpen Access
Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study
European Journal of Surgical Oncology·2021· 38 cited
COVID‐19 pneumonia in kidney transplant recipients: A promising treatment algorithm in the absence of a disease‐specific drug
Journal of Medical Virology·2021· 11 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Adam Uslu(19), Hakan Postacı(11), Cenk Şimşek(9), Funda Taşlı(9), Enver Vardar(8), Raika Durusoy(8), Özlem Özdemir(8), Ahmet Aykas(8), Ülkem Yararbaş(7), Nüket Eliyatkın(6), Murat Karataş(6), Ali Galip Deneçli(6), Zehra Hilal Adıbelli(6), Neslihan Cabıoğlu(5), Hasan Karanlık(5), Mustafa Tükenmez(5), Yeliz Emine Ersoy(5), Selman Emiroğlu(5), Levent Yenıay(5), Enver Özkurt(5)